[1] Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark
[2] Bellvitge Biomed Res Inst, Catalan Inst Oncol, Canc Epigenet & Biol Program, Barcelona 08908, Catalonia, Spain
[3] Bellvitge Biomed Res Inst, Catalan Inst Oncol, Biomarkers & Susceptibil Unit, Spanish Biomed Res Ctr Network Epidemiol & Publ H, Barcelona 08908, Catalonia, Spain
[4] Beijing Genom Inst Europe, DK-2200 Copenhagen N, Denmark
[5] Beijing Genom Inst, Shenzhen, Guangdong, Peoples R China
[6] Univ Coimbra, Ctr Neurosci & Cell Biol, Programme Expt Biol & Biomed, P-3000 Coimbra, Portugal
[7] Spanish Natl Canc Res Ctr, Struct Biol & Biocomp Programme, Madrid, Spain
[8] Univ Salerno, Fac Med, I-84081 Baronissi, Italy
[9] Ist Ricovero Cura Carattere Sci Multimed, Genet Unit, Cardiovasc Res Inst, Sesto San Giovanni, Italy
[10] Univ Barcelona, Fundacio St Joan de Deu, Hosp St Joan de Deu, Neonatal Unit, Barcelona, Catalonia, Spain
[11] Univ Hosp Bellvitge, Internal Med Serv, Barcelona, Catalonia, Spain
[12] Univ Oviedo, Inst Univ Oncol Principado Asturias, Hosp Univ Cent Asturias, Oviedo, Spain
[13] Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain
[14] Ctr Nacl Anal Genom, Barcelona, Catalonia, Spain
[15] Univ Copenhagen, Dept Biol, DK-1168 Copenhagen, Denmark
[16] Univ Barcelona, Sch Med, Dept Physiol Sci 2, Barcelona, Catalonia, Spain
[17] Inst Catalana Recerca & Estudis Avancats, Barcelona, Catalonia, Spain